Less invasive ventilation use grows dramatically, without needed data

October 19, 2020

More research is needed before a less invasive form of ventilation is used near the end of life for patients who have cancer and dementia, recommends the authors of a scientific paper published in JAMA Internal Medicine.

While analyzing data from nearly 2.5 million Medicare-funded hospitalizations within the last 30 days of a patient's life, the researchers found overall use of non-invasive ventilation increased substantially. That increase was nearly nine-fold, going from 0.8% of patients in 2000 to 7.1% of patients 2017. This change came without much data measuring the therapy's effectiveness for certain patient groups such as those with cancer and dementia, the authors noted.

Non-invasive ventilation delivers air through a face mask to help hospitalized patients breathe, similar to how breathing machines help people with sleep apnea at night. It also avoids some of the drawbacks of mechanical ventilation, such as needing to sedate a patient and insert a tube into the windpipe, both of which increase various health risks and make patient communication difficult.

Studies have shown non-invasive ventilation can help hospitalized patients with congestive heart failure and chronic lung disease. However, there is very little data supporting non-invasive ventilation use for hospitalized patients who are near the end of life and have breathing problems from other diseases such as cancer and dementia. Some small studies suggest this therapy also may provide cancer patients with more quality time with their loved ones toward the end of life.

"But just because non-invasive ventilation can work well for some patients, that doesn't automatically mean it will work well for others," said Donald Sullivan, M.D., M.A., M.C.R., the paper's lead author. "More hospitalized patients are using non-invasive ventilation toward the end of their lives, even though there isn't a lot of evidence that clearly lays out the therapy's pros and cons.

"To help our patients and their families make informed decisions, we need to know more about when non-invasive ventilation may be helpful, and when it might be harmful," added Sullivan, who is also an associate professor of medicine (pulmonary and critical care medicine) in the OHSU School of Medicine.

Wearing a mask can make patients with altered cognition anxious and distressed. People dying of dementia may need to be sedated to receive this therapy. Ultimately, this therapy could prolong suffering for patients near the end of life, Sullivan said.

Sullivan and his co-authors recommend pursuing randomized clinical trials to evaluate the safety and effectiveness of non-invasive ventilation in different patient groups.
-end-
This study was supported by the National Institute on Aging, which is a component of the National Institutes of Health (grants R56AG06373748 and 2P01AG027296-11).

REFERENCE:
Donald R. Sullivan, Hyosin Kim, Pedro Gozalo, Jennifer Bunker, Joan M. Teno, "Trends in Non-Invasive and Invasive Mechanical Ventilation among Medicare Beneficiaries at the End of Life," JAMA IM, Oct. 19, 2020, DOI:10.1001/jamainternmed.2020.5640
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2771820.

Oregon Health & Science University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.